This 8-K filing announces the definitive agreement for CD&R and McKesson to acquire Option Care Health for $32.05 per share, valuing the company at approximately $5.8 billion. This is a significant corporate action that will result in Option Care Health becoming a privately held entity with CD&R holding a majority stake and McKesson a minority stake, impacting its public trading status.
Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $32.05 per share, representing a significant premium for OPCH shareholders. This transaction will take Option Care Health private, removing it from public trading and providing a clear exit for current investors at the agreed-upon price. For McKesson, this represents a strategic investment in the home and alternate site infusion services market, expanding its footprint in a growing sector without taking full control. The short-term implication for OPCH is a price convergence towards the acquisition price, while for MCK, it's a long-term strategic play with potential for synergy and market expansion. The key opportunity for traders is to capitalize on the spread between the current market price and the acquisition price for OPCH, assuming the deal closes as expected.